Two Sigma Advisers’s BRAINSTORM CELL THERAPUTC BCLI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-733
| Closed | -$37K | – | 2660 |
|
|
2022
Q1 | $37K | Sell |
733
-40
| -5% | -$2.02K | ﹤0.01% | 2619 |
|
|
2021
Q4 | $46K | Buy |
773
+60
| +8% | +$3.57K | ﹤0.01% | 2479 |
|
|
2021
Q3 | $35K | Sell |
713
-600
| -46% | -$29.5K | ﹤0.01% | 2390 |
|
|
2021
Q2 | $75K | Sell |
1,313
-6,714
| -84% | -$384K | ﹤0.01% | 2364 |
|
|
2021
Q1 | $461K | Buy |
+8,027
| New | +$461K | ﹤0.01% | 2048 |
|